Open Label Study of Sildenafil in Subjects With Pulmonary Arterial Hypertension - Trial 2014-004167-20

Name: Clinical Trial 2014-004167-20
Creator: Pfizer Japan Inc
Keywords: Pulmonary Arterial Hypertension, Phase 3, clinical trial

Access comprehensive clinical trial information for 2014-004167-20 through Pure Global AI's free database. This Phase 3 trial is sponsored by Pfizer Japan Inc and is currently status unknown. The study focuses on Pulmonary Arterial Hypertension.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2014-004167-20

Phase 3

Trial Details

EU Clinical Trials Register • 2014-004167-20

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Open Label Study of Sildenafil in Subjects With Pulmonary Arterial Hypertension

Study Focus

Disease/Condition

Pulmonary Arterial Hypertension

Sponsor & Location

Primary Sponsor

Pfizer Japan Inc

Timeline & Enrollment

Phase

Phase 3

Start Date

N/A

End Date

N/A

ICD-10 Classifications

Primary pulmonary hypertension

Other secondary pulmonary hypertension

Pulmonary heart disease and diseases of pulmonary circulation

Stenosis of pulmonary artery

Pulmonary heart disease, unspecified

Data Source

Registry

EU Clinical Trials Register

Trial ID

2014-004167-20

Type

Non-Device Trial